Merck Buyback
OLI recorded this information on 11/29/2017
Company: |
Merck |
Buyback: |
MRK buyback |
$Amount Authorized: |
$10,000,000,000 |
Buyback Details: |
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has increased the company's quarterly dividend to $0.48 per outstanding share of the company's common stock, up $0.01 from $0.47 per outstanding share paid last quarter. Payment will be made on Jan. 8, 2018, to stockholders of record at the close of business on Dec. 15, 2017. The Board also authorized an additional $10 billion of treasury stock purchases with no time limit for completion. |
Merck & Co. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Co.'s reportable segments are: the Pharmaceutical and Animal Health. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceuticals, vaccines and health management solutions and services, as well as a suite of digitally connected identification, traceability and monitoring products.
Merck SEC Filing Email Alerts Service
Open the MRK Page at The Online Investor »
Company Name: |
Merck & Co Inc |
Stock buyback: |
MRK buyback |
Website: |
www.merck.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding MRK: |
147 |
Total Market Value Held by ETFs: |
$44.36B |
Total Market Capitalization: |
$321.34B |
% of Market Cap. Held by ETFs: |
13.81% |
|
Open the MRK Page at The Online Investor (in a new window) »